BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31616640)

  • 1. Stereotactic Body Radiation Therapy (SBRT) as Salvage Therapy for Oligorecurrent Pleural Mesothelioma After Multi-Modality Therapy.
    Schröder C; Opitz I; Guckenberger M; Stahel R; Weder W; Förster R; Andratschke N; Lauk O
    Front Oncol; 2019; 9():961. PubMed ID: 31616640
    [No Abstract]   [Full Text] [Related]  

  • 2. Stereotactic Body Radiation Therapy (SBRT) for Oligorecurrent/Oligoprogressive Mediastinal and Hilar Lymph Node Metastasis: A Systematic Review.
    Cozzi S; Alì E; Bardoscia L; Najafi M; Botti A; Blandino G; Giaccherini L; Ruggieri MP; Augugliaro M; Iori F; Sardaro A; Iotti C; Ciammella P
    Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage radiotherapy for oligo-progressive malignant pleural mesothelioma.
    Ghirardelli P; Franceschini D; D'Aveni A; Dominici L; Ravasio A; Marzo M; Villa E; Di Noia V; Scorsetti M; Vavassori V; Ceresoli GL
    Lung Cancer; 2021 Feb; 152():1-6. PubMed ID: 33310300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring All Avenues for Radiotherapy in Oligorecurrent Prostate Cancer Disease Limited to Lymph Nodes: A Systematic Review of the Role of Stereotactic Body Radiotherapy.
    Ponti E; Lancia A; Ost P; Trippa F; Triggiani L; Detti B; Ingrosso G
    Eur Urol Focus; 2017 Dec; 3(6):538-544. PubMed ID: 28801240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of stereotactic body radiation therapy for malignant pleural mesothelioma.
    Shin JY; Offin M; Simone CB; Zhang Z; Shepherd AF; Wu AJ; Shaverdian N; Gelblum DY; Gomez DR; Sauter JL; Ginsberg MS; Adusumilli PS; Rusch VW; Zauderer MG; Rimner A
    Radiother Oncol; 2024 Feb; 191():110057. PubMed ID: 38104783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions.
    Wild AT; Hiniker SM; Chang DT; Tran PT; Khashab MA; Limaye MR; Laheru DA; Le DT; Kumar R; Pai JS; Hargens B; Sharabi AB; Shin EJ; Zheng L; Pawlik TM; Wolfgang CL; Koong AC; Herman JM
    J Gastrointest Oncol; 2013 Dec; 4(4):343-51. PubMed ID: 24294505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose hypofractionated stereotactic body radiotherapy for spinal chordoma.
    Chen X; Lo SL; Bettegowda C; Ryan DM; Gross JM; Hu C; Kleinberg L; Sciubba DM; Redmond KJ
    J Neurosurg Spine; 2021 Aug; 35(5):674-683. PubMed ID: 34388713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).
    Scorsetti M; Comito T; Cozzi L; Clerici E; Tozzi A; Franzese C; Navarria P; Fogliata A; Tomatis S; D'Agostino G; Iftode C; Mancosu P; Ceriani R; Torzilli G
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1301-9. PubMed ID: 25644863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic body radiotherapy for extra-cranial oligoprogressive or oligorecurrent small-cell lung cancer.
    Levy A; Khalifa J; Martin E; Botticella A; Quevrin C; Lavaud P; Aldea M; Besse B; Planchard D; Barlesi F; Deutsch E; Massabeau C; Doyen J; Le Péchoux C
    Clin Transl Radiat Oncol; 2023 Jul; 41():100637. PubMed ID: 37206411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma.
    Gkika E; Hallauer L; Kirste S; Adebahr S; Bartl N; Neeff HP; Fritsch R; Brass V; Nestle U; Grosu AL; Brunner TB
    BMC Cancer; 2017 Nov; 17(1):781. PubMed ID: 29162055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT?
    Park HJ; Kim HJ; Won JH; Lee SC; Chang AR
    Technol Cancer Res Treat; 2015 Apr; 14(2):159-67. PubMed ID: 24502552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Stereotactic Body Radiation Therapy for Locoregional Recurrences After Prior Chemoradiation for Advanced Esophageal Carcinoma.
    Seyedin SN; Gannon MK; Plichta KA; Abushahin L; Berg DJ; Arshava EV; Parekh KR; Keech JC; Caster JM; Welsh JW; Allen BG
    Front Oncol; 2020; 10():1311. PubMed ID: 32850412
    [No Abstract]   [Full Text] [Related]  

  • 13. Stereotactic body radiation therapy for adrenal metastases: a retrospective review of a noninvasive therapeutic strategy.
    Torok J; Wegner RE; Burton SA; Heron DE
    Future Oncol; 2011 Jan; 7(1):145-51. PubMed ID: 21174545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
    Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
    J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic body radiotherapy for the treatment of oligometastatic gynecological malignancy in the abdomen and pelvis: A single-institution experience.
    Smile TD; Reddy CA; Qiao-Guan G; Winter WI; Stephans KL; Woody NM; Balagamwala EH; Amarnath SR; Magnelli A; AlHilli MM; Michener CM; Mahdi H; DeBernardo RL; Rose PG; Cherian SS
    J Radiosurg SBRT; 2021; 7(3):189-197. PubMed ID: 33898082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reirradiation with stereotactic body radiation therapy after prior conventional fractionation radiation for locally recurrent pancreatic adenocarcinoma.
    Koong AJ; Toesca DAS; von Eyben R; Pollom EL; Chang DT
    Adv Radiat Oncol; 2017; 2(1):27-36. PubMed ID: 28740913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiotherapy prolongs the progression-free survival and delays the change of systemic therapy regimen in patients with lung oligoprogressive metastatic colorectal cancer.
    Li S; Dong D; Geng J; Zhu X; Shi C; Zhang Y; Wang H; Zhou S; Wu H; Cai Y; Li Y; Wang W
    Asia Pac J Clin Oncol; 2022 Apr; 18(2):e64-e72. PubMed ID: 33629479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic Body Radiation Therapy for Locally Progressive and Recurrent Pancreatic Cancer after Prior Radiation.
    Sutera P; Bernard ME; Wang H; Bahary N; Burton S; Zeh H; Heron DE
    Front Oncol; 2018; 8():52. PubMed ID: 29564223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic Body Radiation Therapy as Salvage for Intrathoracic Recurrence in Patients With Previously Irradiated Locally Advanced Non-Small Cell Lung Cancer.
    Parks J; Kloecker G; Woo S; Dunlap NE
    Am J Clin Oncol; 2016 Apr; 39(2):147-53. PubMed ID: 24457534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage Stereotactic Body Radiotherapy for Isolated Lymph Node Recurrent Prostate Cancer: Single Institution Series of 94 Consecutive Patients and 124 Lymph Nodes.
    Jereczek-Fossa BA; Fanetti G; Fodor C; Ciardo D; Santoro L; Francia CM; Muto M; Surgo A; Zerini D; Marvaso G; Timon G; Romanelli P; Rondi E; Comi S; Cattani F; Golino F; Mazza S; Matei DV; Ferro M; Musi G; Nolè F; de Cobelli O; Ost P; Orecchia R
    Clin Genitourin Cancer; 2017 Aug; 15(4):e623-e632. PubMed ID: 28185875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.